Biomarkers for Immunotherapy of Oral Squamous Cell Carcinoma: Current Status and Challenges

by Alhadi Almangush, Alhadi Almangush, Alhadi Almangush, Alhadi Almangush, Alhadi Almangush, Ilmo Leivo, Ilmo Leivo, Antti A. Mäkitie, Antti A. Mäkitie, Antti A. Mäkitie
Published 2021-03-01

Utilizing Deep Machine Learning for Prognostication of Oral Squamous Cell Carcinoma—A Systematic Review

by Rasheed Omobolaji Alabi, Rasheed Omobolaji Alabi, Ibrahim O. Bello, Omar Youssef, Omar Youssef, Mohammed Elmusrati, Antti A. Mäkitie, Antti A. Mäkitie, Antti A. Mäkitie, Alhadi Almangush, Alhadi Almangush, Alhadi Almangush, Alhadi Almangush
Published 2021-07-01

Mitigating Burnout in an Oncological Unit: A Scoping Review

by Rasheed Omobolaji Alabi, Rasheed Omobolaji Alabi, Päivi Hietanen, Mohammed Elmusrati, Omar Youssef, Omar Youssef, Alhadi Almangush, Alhadi Almangush, Alhadi Almangush, Antti A. Mäkitie, Antti A. Mäkitie, Antti A. Mäkitie
Published 2021-10-01

Characteristics of Laryngeal Osteosarcoma: A Critical Review

by Antti A. Mäkitie, Kenneth O. Devaney, Bertrand Baujat, Alhadi Almangush, Alfio Ferlito
Published 2020-02-01

The expression and prognostic value of stem cell markers Bmi-1, HESC5:3, and HES77 in human papillomavirus–positive and –negative oropharyngeal squamous cell carcinoma

by Hesham Mohamed, Jaana Hagström, Lauri Jouhi, Timo Atula, Alhadi Almangush, Antti Mäkitie, Caj Haglund
Published 2019-03-01

Clinical significance of tumor-stroma ratio in head and neck cancer: a systematic review and meta-analysis

by Alhadi Almangush, Rasheed Omobolaji Alabi, Giuseppe Troiano, Ricardo D. Coletta, Tuula Salo, Matti Pirinen, Antti A. Mäkitie, Ilmo Leivo
Published 2021-04-01

Cell-in-cell phenomenon associates with aggressive characteristics and cancer-related mortality in early oral tongue cancer

by Alhadi Almangush, Antti A. Mäkitie, Jaana Hagström, Caj Haglund, Luiz Paulo Kowalski, Pentti Nieminen, Ricardo D. Coletta, Tuula Salo, Ilmo Leivo
Published 2020-09-01

Improving Risk Stratification of Early Oral Tongue Cancer with TNM-Immune (TNM-I) Staging System

by Alhadi Almangush, Ibrahim O. Bello, Ilkka Heikkinen, Jaana Hagström, Caj Haglund, Luiz Paulo Kowalski, Ricardo D. Coletta, Antti A. Mäkitie, Tuula Salo, Ilmo Leivo
Published 2021-06-01

High tumor mutation burden predicts favorable outcome among patients with aggressive histological subtypes of lung adenocarcinoma: A population-based single-institution study

by Eva-Maria Talvitie, Heikki Vilhonen, Samu Kurki, Antti Karlsson, Katri Orte, Alhadi Almangush, Hesham Mohamed, Lassi Liljeroos, Yajuvinder Singh, Ilmo Leivo, Tarja Laitinen, Markku Kallajoki, Pekka Taimen
Published 2020-09-01